Designing Isoform-selective Inhibitors Against Classical HDACs for Effective Anticancer Therapy: Insight and Perspectives from In Silico

By  

Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. : 815-824

Bentham Science Publishers

Access to resources Recommend Favorite

Aspartic Protease Inhibitors: Effective Drugs against the Human Fungal Pathogen Candida albicans

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 155-162

Bentham Science Publishers

Access to resources Recommend Favorite

The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6155-6168

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of Hsp90 Inhibitors as Anti-Cancer Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1137-1143

Bentham Science Publishers

Access to resources Recommend Favorite

Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?

By Susva M.   Missbach M.   Green J.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. : 489-495

Elsevier

Access to resources Recommend Favorite